Osteoarthritis: pathogenic signaling pathways and therapeutic targets

Остеоартрит: патогенные сигнальные пути и терапевтические мишени
Qing Yao, Tailin He, Guozhi Xiao, Sheng Chen, Yiming Zhong, Xiaohao Wu, Chu Tao, Weiyuan Gong, Mingjue Chen, Minghao Qu, Qing Yao
2023-02-03

NF-κB signalingWnt/β-catenin signalingosteoarthritispathological signaling pathwaystherapeutic targets
Osteoarthritis (OA) is a chronic degenerative joint disorder that leads to disability and affects more than 500 million population worldwide. OA was believed to be caused by the wearing and tearing of articular cartilage, but it is now more commonly referred to as a chronic whole-joint disorder that is initiated with biochemical and cellular alterations in the synovial joint tissues, which leads to the histological and structural changes of the joint and ends up with the whole tissue dysfunction. Currently, there is no cure for OA, partly due to a lack of comprehensive understanding of the pathological mechanism of the initiation and progression of the disease. Therefore, a better understanding of pathological signaling pathways and key molecules involved in OA pathogenesis is crucial for therapeutic target design and drug development. In this review, we first summarize the epidemiology of OA, including its prevalence, incidence and burdens, and OA risk factors. We then focus on the roles and regulation of the pathological signaling pathways, such as Wnt/β-catenin, NF-κB, focal adhesion, HIFs, TGFβ/ΒΜP and FGF signaling pathways, and key regulators AMPK, mTOR, and RUNX2 in the onset and development of OA. In addition, the roles of factors associated with OA, including MMPs, ADAMTS/ADAMs, and PRG4, are discussed in detail. Finally, we provide updates on the current clinical therapies and clinical trials of biological treatments and drugs for OA. Research advances in basic knowledge of articular cartilage biology and OA pathogenesis will have a significant impact and translational value in developing OA therapeutic strategies.
1
AMPK, mTOR, RUNX2, MMPs, ADAMTS/ADAMs, and PRG4 are highlighted as key molecular regulators or factors involved in OA pathogenesis.
2
Improved understanding of articular cartilage biology, pathogenic signaling, and molecular targets is expected to support development of biological therapies and drugs for OA.
3
OA currently has no cure, partly because the mechanisms driving disease initiation and progression remain incompletely understood.
4
Osteoarthritis is characterized as a chronic whole-joint disorder initiated by biochemical and cellular alterations, rather than simple cartilage wear and tear.
5
The review identifies Wnt/β-catenin, NF-κB, focal adhesion, HIF, TGFβ/BMP, and FGF signaling pathways as central regulators of OA onset and progression.

osteoarthritis as a chronic whole-joint disorder

pathogenic signaling pathways, key molecular regulators, and therapeutic targets involved in OA onset and progression

Publication Details
Publication Date
2023-02-03
Journal
Publisher
ISSN
Cited by
1414
Access Type
Author Information
Authors
Qing Yao
Tailin He
Guozhi Xiao
Sheng Chen
Yiming Zhong
Xiaohao Wu
Chu Tao
Weiyuan Gong
Mingjue Chen
Minghao Qu
Qing Yao
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%